Page last updated: 2024-12-06

sufosfamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

sufosfamide: stronger immunosuppressive activity than cyclophosphamide; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65805
CHEMBL ID471721
SCHEMBL ID11091942
MeSH IDM0048440

Synonyms (20)

Synonym
ethanol, 2-((3-(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-yl)amino)-, methanesulfonate (ester), p-oxide
2-((3-(2-chloroethyl)tetrahydro-2h-1,3,2-oxazaphosphorin-2-yl)amino)ethanol methanesulfonate (ester) p-oxide
3-(2-chloroethyl)-2-(2-mesyloxyethylamino)tetrahydro-2h-1,3,2-oxazaphosphorin-2-oxide
sufosfamide [inn]
sufosfamidum [inn-latin]
sufosfamido [inn-spanish]
sufosfamide
asta 5122
CHEMBL471721
37753-10-9
sufosfamido
unii-2208y59985
sufosfamidum
2208y59985 ,
ethanol, 2-((3-(2-chloroethyl)tetrahydro-2-oxido-2h-1,3,2-oxazaphosphorin-2-yl)amino)-, 1-methanesulfonate
SCHEMBL11091942
Q27253597
2-[[3-(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-yl]amino]ethyl methanesulfonate
DTXSID10865884
2-{[3-(2-chloroethyl)-2-oxo-1,3,2lambda~5~-oxazaphosphinan-2-yl]amino}ethyl methanesulfonate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (16.67%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]